Piermont Capital Management Inc. - AGIOS PHARMACEUTICALS INC ownership

AGIOS PHARMACEUTICALS INC's ticker is AGIO and the CUSIP is 00847X104. A total of 165 filers reported holding AGIOS PHARMACEUTICALS INC in Q3 2016. The put-call ratio across all filers is 0.81 and the average weighting 0.4%.

Quarter-by-quarter ownership
Piermont Capital Management Inc. ownership history of AGIOS PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2017$977,000
-13.8%
18,980
-2.3%
0.28%
+3.3%
Q1 2017$1,134,000
+134.3%
19,420
+67.4%
0.27%
+143.2%
Q4 2016$484,000
-22.6%
11,600
-1.9%
0.11%
-25.0%
Q3 2016$625,00011,8300.15%
Other shareholders
AGIOS PHARMACEUTICALS INC shareholders Q3 2016
NameSharesValueWeighting ↓
Eagle Health Investments LP 354,650$18,314,0007.19%
Casdin Capital, LLC 2,165,000$111,801,0003.33%
Rock Springs Capital Management LP 2,543,600$131,352,0002.87%
HealthCor Management, L.P. 1,532,960$79,162,0002.80%
Bellevue Group AG 4,537,092$234,295,0002.48%
Woodline Partners LP 824,097$42,556,0000.94%
SUVRETTA CAPITAL MANAGEMENT, LLC 1,081,347$55,841,0000.83%
Integral Health Asset Management, LLC 43,000$2,221,0000.64%
ArrowMark Colorado Holdings LLC 1,119,566$57,814,0000.43%
Virtus ETF Advisers LLC 18,328$946,0000.40%
View complete list of AGIOS PHARMACEUTICALS INC shareholders